These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12823555)

  • 1. Covalent binding to glutathione of the DNA-alkylating antitumor agent, S23906-1.
    David-Cordonnier MH; Laine W; Joubert A; Tardy C; Goossens JF; Kouach M; Briand G; Thi Mai HD; Michel S; Tillequin F; Koch M; Leonce S; Pierre A; Bailly C
    Eur J Biochem; 2003 Jul; 270(13):2848-59. PubMed ID: 12823555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of novel antitumor DNA alkylating agents: the benzacronycine series.
    David-Cordonnier MH; Laine W; Gaslonde T; Michel S; Tillequin F; Koch M; Léonce S; Pierré A; Bailly C
    Curr Med Chem Anticancer Agents; 2004 Mar; 4(2):83-92. PubMed ID: 15032716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkylation of guanine in DNA by S23906-1, a novel potent antitumor compound derived from the plant alkaloid acronycine.
    David-Cordonnier MH; Laine W; Lansiaux A; Kouach M; Briand G; Pierré A; Hickman JA; Bailly C
    Biochemistry; 2002 Aug; 41(31):9911-20. PubMed ID: 12146956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the stereoisomeric position of the reactive acetate groups of the benzo[b]acronycine derivative S23906-1 on its DNA alkylation, helix-opening, cytotoxic, and antitumor activities.
    Depauw S; Gaslonde T; Léonce S; Kraus-Berthier L; Laine W; Lenglet G; Chiaroni A; Pfeiffer B; Bailly C; Michel S; Tillequin F; Pierré A; David-Cordonnier MH
    Mol Pharmacol; 2009 Dec; 76(6):1172-85. PubMed ID: 19752199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A transesterification reaction is implicated in the covalent binding of benzo[b]acronycine anticancer agents with DNA and glutathion.
    David-Cordonnier MH; Laine W; Kouach M; Briand G; Vezin H; Gaslonde T; Michel S; Doan Thi Mai H; Tillequin F; Koch M; Léonce S; Pierré A; Bailly C
    Bioorg Med Chem; 2004 Jan; 12(1):23-9. PubMed ID: 14697766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: implications for recognition and repair of antitumor alkylators.
    Rocca CJ; Poindessous V; Soares DG; Ouadrani KE; Sarasin A; Guérin E; de Gramont A; Henriques JA; Escargueil AE; Larsen AK
    Biochem Pharmacol; 2010 Aug; 80(3):335-43. PubMed ID: 20399198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA2 is needed for both repair and cell cycle arrest in mammalian cells exposed to S23906, an anticancer monofunctional DNA binder.
    Rocca CJ; Soares DG; Bouzid H; Henriques JA; Larsen AK; Escargueil AE
    Cell Cycle; 2015; 14(13):2080-90. PubMed ID: 25945522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, cytotoxic activity, and DNA binding properties of antitumor cis-1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine cinnamoyl esters.
    Do Q; Tian W; Yougnia R; Gaslonde T; Pfeiffer B; Pierré A; Léonce S; Kraus-Berthier L; David-Cordonnier MH; Depauw S; Lansiaux A; Mazinghien R; Koch M; Tillequin F; Michel S; Dufat H
    Bioorg Med Chem; 2009 Mar; 17(5):1918-27. PubMed ID: 19217791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in HL-60 leukemia and B16 melanoma cells by the acronycine derivative S23906-1.
    Kluza J; Lansiaux A; Wattez N; Hildebrand MP; Léonce S; Pierré A; Hickman JA; Bailly C
    Biochem Pharmacol; 2002 Apr; 63(8):1443-52. PubMed ID: 11996885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein recognition of the S23906-1-DNA adduct by nuclear proteins: direct involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
    Lenglet G; Depauw S; Mendy D; David-Cordonnier MH
    Biochem J; 2013 May; 452(1):147-59. PubMed ID: 23409959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of replication-dependent double-strand breaks by the novel N2-G-alkylator S23906-1.
    Léonce S; Kraus-Berthier L; Golsteyn RM; David-Cordonnier MH; Tardy C; Lansiaux A; Poindessous V; Larsen AK; Pierré A
    Cancer Res; 2006 Jul; 66(14):7203-10. PubMed ID: 16849567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent binding of antitumor benzoacronycines to double-stranded DNA induces helix opening and the formation of single-stranded DNA: unique consequences of a novel DNA-bonding mechanism.
    David-Cordonnier MH; Laine W; Lansiaux A; Rosu F; Colson P; de Pauw E; Michel S; Tillequin F; Koch M; Hickman JA; Pierré A; Bailly C
    Mol Cancer Ther; 2005 Jan; 4(1):71-80. PubMed ID: 15657355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis.
    Léonce S; Pérez V; Lambel S; Peyroulan D; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman JA; Pierré A
    Mol Pharmacol; 2001 Dec; 60(6):1383-91. PubMed ID: 11723246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Recognition in Drug-Induced DNA Alkylation: When the Moonlight Protein GAPDH Meets S23906-1/DNA Minor Groove Adducts.
    Savreux-Lenglet G; Depauw S; David-Cordonnier MH
    Int J Mol Sci; 2015 Nov; 16(11):26555-81. PubMed ID: 26556350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acronycine derivatives: a promising series of anticancer agents.
    Nguyen QC; Nguyen TT; Yougnia R; Gaslonde T; Dufat H; Michel S; Tillequin F
    Anticancer Agents Med Chem; 2009 Sep; 9(7):804-15. PubMed ID: 19594412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual DNA binding compound, S23906, induces mitotic catastrophe in cultured human cells.
    Cahuzac N; Studény A; Marshall K; Versteege I; Wetenhall K; Pfeiffer B; Léonce S; Hickman JA; Pierré A; Golsteyn RM
    Cancer Lett; 2010 Mar; 289(2):178-87. PubMed ID: 19758748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships and mechanism of action of antitumor benzo[b]pyrano[3,2-h]acridin-7-one acronycine analogues.
    Thi Mai HD; Gaslonde T; Michel S; Tillequin F; Koch M; Bongui JB; Elomri A; Seguin E; Pfeiffer B; Renard P; David-Cordonnier MH; Laine W; Bailly C; Kraus-Berthier L; Léonce S; Hickman JA; Pierré A
    J Med Chem; 2003 Jul; 46(14):3072-82. PubMed ID: 12825945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzo[b]acronycine derivatives: a novel class of antitumor agents.
    Michel S; Gaslonde T; Tillequin F
    Eur J Med Chem; 2004 Aug; 39(8):649-55. PubMed ID: 15276298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of a role of glutathione in cellular nonenzymatic activation of BMS-181174, a novel analogue of mitomycin C.
    Xia H; Pinto T; Hu X; Benson PJ; Zaren HA; Gupta V; Singh S
    Cancer Res; 1996 Aug; 56(15):3495-8. PubMed ID: 8758917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acronycine derivatives as promising antitumor agents.
    Guilbaud N; Léonce S; Tillequin F; Koch M; Hickman JA; Pierré A
    Anticancer Drugs; 2002 Jun; 13(5):445-9. PubMed ID: 12045455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.